MKKGY
Price
$29.14
Change
-$0.36 (-1.22%)
Updated
Jan 17 closing price
Capitalization
76.59B
46 days until earnings call
ZTS
Price
$165.89
Change
-$3.48 (-2.05%)
Updated
Jan 17 closing price
Capitalization
77.48B
25 days until earnings call
Ad is loading...

MKKGY vs ZTS

Header iconMKKGY vs ZTS Comparison
Open Charts MKKGY vs ZTSBanner chart's image
Merck KGaA
Price$29.14
Change-$0.36 (-1.22%)
Volume$195.82K
Capitalization76.59B
ZOETIS
Price$165.89
Change-$3.48 (-2.05%)
Volume$4.66M
Capitalization77.48B
MKKGY vs ZTS Comparison Chart
Loading...
MKKGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MKKGY vs. ZTS commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MKKGY is a Hold and ZTS is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (MKKGY: $29.14 vs. ZTS: $165.89)
Brand notoriety: MKKGY: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: MKKGY: 119% vs. ZTS: 182%
Market capitalization -- MKKGY: $76.59B vs. ZTS: $77.48B
MKKGY [@Pharmaceuticals: Other] is valued at $76.59B. ZTS’s [@Pharmaceuticals: Other] market capitalization is $77.48B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MKKGY’s FA Score shows that 1 FA rating(s) are green whileZTS’s FA Score has 1 green FA rating(s).

  • MKKGY’s FA Score: 1 green, 4 red.
  • ZTS’s FA Score: 1 green, 4 red.
According to our system of comparison, ZTS is a better buy in the long-term than MKKGY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MKKGY’s TA Score shows that 3 TA indicator(s) are bullish while ZTS’s TA Score has 5 bullish TA indicator(s).

  • MKKGY’s TA Score: 3 bullish, 4 bearish.
  • ZTS’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, ZTS is a better buy in the short-term than MKKGY.

Price Growth

MKKGY (@Pharmaceuticals: Other) experienced а -0.27% price change this week, while ZTS (@Pharmaceuticals: Other) price change was +1.57% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.30%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was -9.85%.

Reported Earning Dates

MKKGY is expected to report earnings on May 15, 2025.

ZTS is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.30% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($77.5B) and MKKGY($76.6B) have the same market capitalization . ZTS has higher P/E ratio than MKKGY: ZTS (32.94) vs MKKGY (21.41). ZTS (1.817) and MKKGY (1.781) have similar YTD gains . MKKGY has higher annual earnings (EBITDA): 6.45B vs. ZTS (3.67B). ZTS has more cash in the bank: 2.04B vs. MKKGY (1.72B). ZTS has less debt than MKKGY: ZTS (6.76B) vs MKKGY (10.6B). MKKGY has higher revenues than ZTS: MKKGY (22.3B) vs ZTS (8.54B).
MKKGYZTSMKKGY / ZTS
Capitalization76.6B77.5B99%
EBITDA6.45B3.67B176%
Gain YTD1.7811.81798%
P/E Ratio21.4132.9465%
Revenue22.3B8.54B261%
Total Cash1.72B2.04B84%
Total Debt10.6B6.76B157%
FUNDAMENTALS RATINGS
MKKGY vs ZTS: Fundamental Ratings
MKKGY
ZTS
OUTLOOK RATING
1..100
5010
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
36
Fair valued
PROFIT vs RISK RATING
1..100
6463
SMR RATING
1..100
7221
PRICE GROWTH RATING
1..100
6160
P/E GROWTH RATING
1..100
6875
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MKKGY's Valuation (29) in the null industry is in the same range as ZTS (36) in the Pharmaceuticals Generic industry. This means that MKKGY’s stock grew similarly to ZTS’s over the last 12 months.

ZTS's Profit vs Risk Rating (63) in the Pharmaceuticals Generic industry is in the same range as MKKGY (64) in the null industry. This means that ZTS’s stock grew similarly to MKKGY’s over the last 12 months.

ZTS's SMR Rating (21) in the Pharmaceuticals Generic industry is somewhat better than the same rating for MKKGY (72) in the null industry. This means that ZTS’s stock grew somewhat faster than MKKGY’s over the last 12 months.

ZTS's Price Growth Rating (60) in the Pharmaceuticals Generic industry is in the same range as MKKGY (61) in the null industry. This means that ZTS’s stock grew similarly to MKKGY’s over the last 12 months.

MKKGY's P/E Growth Rating (68) in the null industry is in the same range as ZTS (75) in the Pharmaceuticals Generic industry. This means that MKKGY’s stock grew similarly to ZTS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MKKGYZTS
RSI
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 12 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
57%
Bullish Trend 12 days ago
60%
Momentum
ODDS (%)
Bullish Trend 12 days ago
66%
Bullish Trend 12 days ago
62%
MACD
ODDS (%)
N/A
Bullish Trend 12 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
64%
Bullish Trend 12 days ago
61%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
63%
Bearish Trend 12 days ago
58%
Advances
ODDS (%)
Bullish Trend 13 days ago
63%
Bullish Trend 14 days ago
59%
Declines
ODDS (%)
Bearish Trend 21 days ago
55%
Bearish Trend 21 days ago
54%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
48%
N/A
Aroon
ODDS (%)
Bearish Trend 12 days ago
61%
N/A
View a ticker or compare two or three
Ad is loading...
MKKGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOS7.570.27
+3.70%
SOS Limited
SFST36.980.78
+2.15%
Southern First Bancshares
TCOM67.161.35
+2.05%
Trip.com Group Limited
GOGO7.850.13
+1.68%
Gogo
BOX31.530.03
+0.10%
BOX

MKKGY and

Correlation & Price change

A.I.dvisor indicates that over the last year, MKKGY has been loosely correlated with MKGAF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MKKGY jumps, then MKGAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKKGY
1D Price
Change %
MKKGY100%
-1.22%
MKGAF - MKKGY
49%
Loosely correlated
+1.10%
AMPH - MKKGY
25%
Poorly correlated
+0.11%
ZTS - MKKGY
25%
Poorly correlated
-2.05%
SUPN - MKKGY
25%
Poorly correlated
-0.34%
INDV - MKKGY
24%
Poorly correlated
-0.09%
More

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with SNDL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
-2.05%
SNDL - ZTS
33%
Loosely correlated
-1.11%
ACET - ZTS
31%
Poorly correlated
-1.22%
EVO - ZTS
27%
Poorly correlated
+1.73%
HLN - ZTS
27%
Poorly correlated
+0.54%
ALKS - ZTS
26%
Poorly correlated
-0.94%
More